RXO (NYSE:RXO) Given New $24.00 Price Target at Citigroup

RXO (NYSE:RXO) had its price target upped by equities research analysts at Citigroup from $17.00 to $24.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. Citigroup’s price objective suggests a potential upside of 10.10% from the stock’s current price.

Other analysts have also recently issued reports about the company. UBS Group reaffirmed a “neutral” rating on shares of RXO in a research report on Friday. Wells Fargo & Company lifted their price objective on RXO from $15.00 to $22.00 and gave the company an “equal weight” rating in a research report on Friday. Susquehanna lifted their price objective on RXO from $14.00 to $18.00 and gave the company a “negative” rating in a research report on Friday. Stephens set a $15.00 price objective on RXO in a research report on Monday, February 9th. Finally, Morgan Stanley reaffirmed an “equal weight” rating and set a $22.00 price objective (up from $19.00) on shares of RXO in a research report on Thursday. Two analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Reduce” and a consensus target price of $19.00.

RXO Trading Down 5.7%

Shares of NYSE RXO traded down $1.31 during trading hours on Friday, hitting $21.80. The company’s stock had a trading volume of 2,559,697 shares, compared to its average volume of 2,276,456. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.27 and a current ratio of 1.27. The stock has a market cap of $3.59 billion, a price-to-earnings ratio of -37.58, a P/E/G ratio of 35.08 and a beta of 1.96. RXO has a 12 month low of $10.43 and a 12 month high of $23.37. The business has a 50-day simple moving average of $15.96 and a 200-day simple moving average of $15.01.

RXO (NYSE:RXO) last posted its earnings results on Thursday, May 7th. The company reported ($0.09) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.09). The company had revenue of $1.43 billion for the quarter, compared to analysts’ expectations of $1.34 billion. RXO had a negative return on equity of 0.44% and a negative net margin of 1.74%.RXO’s quarterly revenue was down .6% on a year-over-year basis. During the same period last year, the firm earned ($0.03) earnings per share. On average, analysts anticipate that RXO will post 0.02 earnings per share for the current fiscal year.

Institutional Trading of RXO

Hedge funds have recently made changes to their positions in the stock. Flagship Harbor Advisors LLC bought a new stake in shares of RXO in the 4th quarter worth approximately $25,000. Cassaday & Co Wealth Management LLC bought a new stake in shares of RXO in the 1st quarter worth approximately $29,000. Geneos Wealth Management Inc. bought a new stake in shares of RXO in the 1st quarter worth approximately $30,000. Quarry LP bought a new stake in shares of RXO in the 3rd quarter worth approximately $33,000. Finally, Larson Financial Group LLC boosted its position in shares of RXO by 146.5% in the 3rd quarter. Larson Financial Group LLC now owns 2,766 shares of the company’s stock worth $43,000 after purchasing an additional 1,644 shares in the last quarter. 92.73% of the stock is owned by institutional investors.

Key RXO News

Here are the key news stories impacting RXO this week:

• Positive Sentiment: RXO reported Q1 adjusted results that matched EPS expectations and beat revenue estimates, helping ease concerns about demand trends and Amazon-related weakness. RXO Announces First-Quarter Results and Second-Quarter Outlook
• Positive Sentiment: The company’s Q2 outlook also topped Street expectations, with management projecting $27 million to $37 million in adjusted EBITDA and saying contract rates are trending toward high-single-digit gains. RXO expects $27M-$37M Q2 adjusted EBITDA…
• Positive Sentiment: Management said brokerage momentum is improving, full truckload volume strengthened through the quarter, and higher spot mix should support margins going forward. RXO raises contract rate outlook as Q2 profit seen higher
• Neutral Sentiment: Analysts raised price targets after the report, with TD Cowen lifting its target to $21 and Susquehanna increasing its target to $18, but both firms kept cautious ratings. Analyst updates on RXO
• Negative Sentiment: RXO still posted a quarterly loss, and revenue was slightly down year over year, so investors remain focused on whether improved pricing and volume can translate into sustained profitability. RXO Reports Q1 Loss…

RXO Company Profile

RXO Inc (NYSE: RXO) is a leading asset-light provider of digital freight brokerage and managed transportation solutions. The company leverages a proprietary technology platform to connect shippers with a network of third-party carriers, enabling optimized route planning, real-time shipment tracking, and dynamic pricing. RXO’s end-to-end service model spans full truckload, less-than-truckload (LTL), intermodal and cross-border freight movements, designed to improve efficiency and reduce transportation costs for its customers.

Operating primarily across North America, RXO serves a diverse base of shippers in industries ranging from retail and consumer goods to manufacturing and automotive.